Comparison of clinical responses to natural and synthetic surfactants
- 1 January 1993
- journal article
- clinical trial
- Published by Walter de Gruyter GmbH in jpme
- Vol. 21 (5) , 341-347
- https://doi.org/10.1515/jpme.1993.21.5.341
Abstract
The clinical responses to both natural and synthetic surfactants were observed in two District General Hospital Neonatal Units who were centrally randomised as part of two separate multicentre trials (OSIRIS and Curosurf 4). Forty five infants were enrolled consecutively in the OSIRIS trial using synthetic surfactant (Exosurf), while 21 infants were subsequently enrolled in the Curosurf 4 trial using natural surfactant (Curosurf). There were no significant differences between the groups for mean birth weight, gestational age, inspired oxygen (FiO2), or arterial: alveolar oxygen ratio (a/A) prior to surfactant administration. Oxygen requirements fell significantly more rapidly within the first 24 hours for patients treated with Curosurf compared to Exosurf (p < 0.001). Mean duration of > 40% oxygen requirement was significantly shorter in the Curosurf group (2.6 days) compared to 8.0 days in the Exosurf group (p < 0.01). Mean duration of oxygen therapy was also significantly shorter in the Curosurf group (10.2 days) compared to 17.1 days in the Exosurf group (p < 0.05). Ten infants (24%) in the Exosurf group developed intraventricular haemorrhage (IVH) compared to none in the Curosurf group (p < 0.05). As oxygen requirements appear to decrease more rapidly following administration of Curosurf compared to Exosurf a large prospective randomized multicentre trial needs to be performed to compare the effects of these surfactants on both short and long-term outcome.Keywords
This publication has 20 references indexed in Scilit:
- Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 gramsThe Journal of Pediatrics, 1992
- Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trialThe Journal of Pediatrics, 1991
- A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndromeEuropean Journal of Pediatrics, 1990
- A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infantsThe Journal of Pediatrics, 1990
- A Multicenter Randomized, Placebo-Controlled Trial of Surfactant Therapy for Respiratory Distress SyndromeNew England Journal of Medicine, 1989
- Severe Neonatal Respiratory Distress Syndrome Treated with the Isolated Phospholipid Fraction of Natural SurfactantActa Paediatrica, 1987
- Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group.BMJ, 1987
- Prophylactic Treatment of Very Premature Infants with Human SurfactantNew England Journal of Medicine, 1986
- Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trialThe Journal of Pediatrics, 1985
- ARTIFICIAL SURFACTANT THERAPY IN HYALINE-MEMBRANE DISEASEThe Lancet, 1980